Pharmatalks
International Channel🎉 @Pharmatalks Chat group ✔️ @Pharmatalks_group Ads تبلیغات🔝 @Pharmatalkads Pharmacopoeia 📚 @USP_2024
Mostrar más📈 Análisis del canal de Telegram Pharmatalks
El canal Pharmatalks (@pharmatalks) en el segmento lingüístico de Inglés es un actor destacado. Actualmente la comunidad reúne a 18 012 suscriptores, ocupando la posición 11 234 en la categoría Educación y el puesto 2 166 en la región EEUU.
📊 Métricas de audiencia y dinámica
Desde su creación el невідомо, el proyecto ha mostrado un crecimiento acelerado, reuniendo a 18 012 suscriptores.
Según los últimos datos del 18 junio, 2026, el canal mantiene una actividad estable. En los últimos 30 días la variación de miembros fue de -82, y en las últimas 24 horas de 0, conservando un alto alcance.
- Estado de verificación: No verificado
- Tasa de interacción (ER): El promedio de interacción de la audiencia es 14.49%. Durante las primeras 24 horas tras publicar, el contenido suele obtener 4.21% de reacciones respecto al total de suscriptores.
- Alcance de las publicaciones: Cada publicación recibe en promedio 2 610 visualizaciones. En el primer día suele acumular 758 visualizaciones.
- Reacciones e interacción: La audiencia responde de forma activa: el promedio de reacciones por publicación es 5.
- Intereses temáticos: El contenido se centra en temas clave como validation, pharma, pharmatalk, qualification, iso.
📝 Descripción y política de contenido
El autor describe el recurso como un espacio para expresar opiniones subjetivas:
“International Channel🎉 @Pharmatalks
Chat group ✔️ @Pharmatalks_group
Ads تبلیغات🔝 @Pharmatalkads
Pharmacopoeia 📚 @USP_2024”
Gracias a la alta frecuencia de actualizaciones (últimos datos recibidos el 19 junio, 2026), el canal mantiene la vigencia y un amplio alcance. La analítica demuestra que la audiencia interactúa activamente con el contenido, lo que lo convierte en un punto de referencia dentro de la categoría Educación.
Carga de datos en curso...
| Fecha | Crecimiento de Suscriptores | Menciones | Canales | |
| 19 junio | 0 | |||
| 18 junio | +1 | |||
| 17 junio | 0 | |||
| 16 junio | 0 | |||
| 15 junio | 0 | |||
| 14 junio | 0 | |||
| 13 junio | 0 | |||
| 12 junio | 0 | |||
| 11 junio | 0 | |||
| 10 junio | 0 | |||
| 09 junio | 0 | |||
| 08 junio | 0 | |||
| 07 junio | +1 | |||
| 06 junio | 0 | |||
| 05 junio | +8 | |||
| 04 junio | +5 | |||
| 03 junio | +27 | |||
| 02 junio | +1 | |||
| 01 junio | 0 |
| 2 | QA vs QM in Project Management: What’s the real difference?
QA helps teams follow the right process.
QM makes sure the whole project delivers quality consistently.
In real projects, both matter. QA prevents mistakes. QM connects quality goals, team performance, risk control, KPIs, and continuous improvement.
Enroll NOW in Pharmaceutical Project Manager Career Path HERE
✅ Pharmaceutical Project Manager Career Path
https://pharmuni.com/career-path/3/pharmaceutical-project-manager | 1 361 |
| 3 | ⚠️ Risk Management in the Pharmaceutical Industry
In pharma, risk management helps teams protect patients, ensure quality, and maintain compliance.
It also supports better decisions before small issues become major problems.
Key risk areas include:
✅ Quality risk
✅ Operational risk
✅ Compliance risk
✅ Supply chain risk
✅ Safety risk
✅ Data integrity risk
✅ Equipment and process risk
Common risk management tools include:
🔹 FMEA
🔹 HAZOP
🔹 Root Cause Analysis
🔹 Risk Matrix
🔹 Pareto Analysis
🔹 Checklists and SOPs
Strong risk management helps pharma teams:
✅ Identify risks early
✅ Prioritize high-impact issues
✅ Reduce deviations and errors
✅ Improve CAPA effectiveness
✅ Strengthen GMP compliance
✅ Support patient safety
Risk management is not just a document.
It is a proactive mindset for safer products and stronger quality systems.
Want to build stronger GMP risk management skills?
👉 Explore Pharmuni’s GMP Risk Management Principles course:
https://pharmuni.com/courses/18/gmp-risk-management-principles | 2 478 |
| 4 | Where Are the Best Biotech and Pharmaceutical Jobs in the USA? 🇺🇸💊
📍 Top States for Biotech and Pharma Careers:
✅ California – Strong biotech hubs, innovation, and research opportunities.
✅ Massachusetts – Known for biotech startups, R&D, and scientific innovation.
✅ New Jersey – Home to major pharmaceutical headquarters and regulatory roles.
✅ North Carolina – Growing opportunities in bioprocessing and manufacturing.
✅ Pennsylvania – Expanding biotech, production, and quality career options.
✅ Texas – Rising demand in clinical research and life sciences manufacturing.
Whether you are starting your career or seeking your next position, focus on the right location, build relevant skills, and explore opportunities consistently.
🚀 Ready to take the next step in your pharmaceutical career?
Explore pharma job opportunities on Pharmuni:
https://l1nq.com/eevf8pq | 2 815 |
| 5 | 🔐 Key Requirements of 21 CFR Part 11 Training
In regulated pharma environments, electronic records and electronic signatures must be controlled, traceable, and reliable.
Teams should understand:
✅ When 21 CFR Part 11 applies
✅ Why computerized systems need validation
✅ How audit trails support traceability
✅ Why access control protects data integrity
✅ How electronic signatures must be managed
✅ Why SOPs and training are essential
✅ How record integrity supports inspection readiness
21 CFR Part 11 is not only an IT topic.
It connects quality, compliance, validation, documentation, and patient safety.
Want to build stronger knowledge in computerized system compliance?
👉 Explore Pharmuni’s Introduction to Computer Systems Validation (CSV) course:
https://shorturl.at/EyAuD | 2 417 |
| 6 | 🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard
.
Key points include:
✅ A structured clinical protocol guideline
✅ A standardized protocol template
✅ A technical specification for digital exchange
✅ Better consistency across trial submissions
✅ Improved clarity for sponsors and regulators
✅ Less ambiguity in protocol content
✅ Stronger support for global clinical trial efficiency
📌 Read the full news here: https://sl1nk.com/kd7xmys | 2 763 |
| 7 | 🚨 FDA Finalizes 3-Part ICH M11 Digital Protocol Standard
.
Key points include:
✅ A structured clinical protocol guideline
✅ A standardized protocol template
✅ A technical specification for digital exchange
✅ Better consistency across trial submissions
✅ Improved clarity for sponsors and regulators
✅ Less ambiguity in protocol content
✅ Stronger support for global clinical trial efficiency
📌 Read the full news here: https://sl1nk.com/kd7xmys | 1 |
| 8 | ⚙️ Common Pitfalls in IQ, OQ, and PQ
.
✅ Incomplete installation records
✅ Missing utility or component checks
✅ Poorly defined test parameters
✅ Untrained personnel running tests
✅ Weak acceptance criteria
✅ Not simulating real operating conditions
✅ Insufficient run data or sampling
✅ Delayed deviation documentation
✅ Poor traceability of qualification records
How can teams avoid these issues?
🔹 Use approved protocols and checklists
🔹 Define acceptance criteria clearly
🔹 Train staff before execution
🔹 Document deviations immediately
🔹 Review results carefully
🔹 Maintain traceable GMP records
Want to strengthen your IQ, OQ, and PQ execution skills?
👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course:
https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification | 2 542 |
| 9 | ⚙️ Common Pitfalls in IQ, OQ, and PQ
.
✅ Incomplete installation records
✅ Missing utility or component checks
✅ Poorly defined test parameters
✅ Untrained personnel running tests
✅ Weak acceptance criteria
✅ Not simulating real operating conditions
✅ Insufficient run data or sampling
✅ Delayed deviation documentation
✅ Poor traceability of qualification records
How can teams avoid these issues?
🔹 Use approved protocols and checklists
🔹 Define acceptance criteria clearly
🔹 Train staff before execution
🔹 Document deviations immediately
🔹 Review results carefully
🔹 Maintain traceable GMP records
Want to strengthen your IQ, OQ, and PQ execution skills?
👉 Explore Pharmuni’s Performing Phase of GMP Equipment Qualification course:
https://pharmuni.com/courses/39/performing-phase-of-gmp-equipment-qualification | 1 |
| 10 | GLP vs GMP Presentation | 3 157 |
| 11 | British Pharmacopoeia Comparison with other USP , EU | 3 848 |
| 12 | Top Pharma Regulatory Bodies
50 MOST ASKED QUESTIONS & ANSWERS | 3 954 |
| 13 | Understanding ICH Quality Guidelines: A Quick Overview 🌍⚙️
The International Council for Harmonisation (ICH) Quality Guidelines are essential for ensuring the safety, efficacy, and quality of pharmaceuticals worldwide. Here's a quick summary to keep you informed:
Watch NOW PHARMATALKS FULL Podcast HERE
https://youtu.be/GhnWNgXbigs?si=MMVwtlBogSMTLAFo
1. Q1 Series (Stability Testing) 🧪
Focuses on stability testing protocols to determine shelf life and storage conditions.
2. Q2(R1) (Analytical Validation) 🔬
Provides guidance on validating analytical procedures to ensure accuracy and reliability.
3. Q3A/B (Impurities) 💊
Addresses impurities in drug substances and products, emphasizing control strategies.
4. Q4B (Pharmacopoeial Harmonization) 📚
Facilitates harmonization of monographs across different pharmacopoeias.
5. Q5 Series (Quality of Biotechnological/ Biological Products) 🧬
Covers quality considerations specific to biotech and biological products. | 2 716 |
| 14 | ICH M11 2026 Update | 4 043 |
¡Ya disponible! Investigación de Telegram 2025 — los principales insights del año 
